Workflow
恒瑞医药(01276.HK)获The Capital Group增持172.82万股
Ge Long Hui·2025-09-23 23:04

Group 1 - The Capital Group Companies, Inc. increased its stake in 恒瑞医药 (Hengrui Medicine) by acquiring 1.7282 million shares at an average price of HKD 87.2873 per share, totaling approximately HKD 151 million [1] - Following the acquisition, The Capital Group's total shareholding in 恒瑞医药 rose to 19.7458 million shares, increasing its ownership percentage from 6.98% to 7.65% [1][2]